Glucagon‐like peptide 1: A potent glycogenic hormone

Authors:
  • MMMónica Morales
    Mónica Morales
  • FCFelipe Clemente
    Felipe Clemente
  • MLMaria I. López-Delgado
    Maria I. López-Delgado
  • EDElena Delgado
    Elena Delgado
  • APAlmudena Perea
    Almudena Perea
  • MVMaria L. Villanueva-Peñacarrillo
    Maria L. Villanueva-Peñacarrillo

Abstract
GLP‐1(7–36)amide is an insulinotropic peptide derived from the intestinal post‐translational proglucagon process, the release of which is increased mainly after a carbohydrate meal; also, its anti‐diabetogenic effect in normal and diabetic states has been reported. In this study, GLP‐1(7–36)amide stimulates the formation of glycogen from glucose in isolated rat hepatocytes, such a glycogenic effect being achieved with physiological concentrations of the peptide. The GLP‐1(7–36)amide‐induced glycogenesis is abolished by glucagon, and it is accompanied by stimulation of the glycogen synthase a activity and by a decrease in the basal and glucagon‐stimulated cyclic AMP content. These findings could explain, at least in part, the GLP‐1(7–36)amide insulin‐independent plasma glucose lowering effect.

This publication has 17 references indexed in Scilit: